Meyer A, Coyle A J, Proudfoot A E, Wells T N, Power C A
Glaxo Institute for Molecular Biology, CH-1228, Plan-les-Ouates, Geneva, Switzerland.
J Biol Chem. 1996 Jun 14;271(24):14445-51. doi: 10.1074/jbc.271.24.14445.
We have cloned a novel CC chemokine receptor cDNA from mouse thymus. The deduced amino acid sequence shows 74% identity to the human monocyte chemotactic protein (MCP)-1 receptor (CC CKR-2b) and 54% to a recently cloned murine macrophage inflammatory protein (MIP)-1alpha receptor (Gao, J. L., and Murphy, P. M.(1995) J. Biol. Chem. 270, 17494-17501). Northern blot analysis of mouse tissues showed that the mRNA was also expressed in heart, spleen and liver, and to a lesser extent in lung and brain. The rank order of CC chemokine competition for 125I-labeled human RANTES (regulated on activation, normal T-cell expressed and secreted) binding to human embryonic kidney (HEK) 293 cells stably transfected with the receptor cDNA was murine MIP-1alpha >> human MIP-1beta > human RANTES > murine RANTES > murine MIP-1beta > human MCP-2 > murine MCP-1 (JE) > human MIP-1alpha > human MCP-3 > human MCP-1. Of the chemokines tested, only murine MIP-1alpha, human and murine MIP-1beta and RANTES, human MCP-2, and JE were able to induce mobilization of intracellular Ca2+ from fura-2-loaded HEK 293 cells expressing the receptor. These results suggest that this receptor functions as a high affinity murine MIP-1alpha receptor; however, it is likely to be an important target for the biological activities of several CC chemokines in mouse.
我们从小鼠胸腺中克隆出一种新型CC趋化因子受体cDNA。推导的氨基酸序列与人类单核细胞趋化蛋白(MCP)-1受体(CC CKR-2b)有74%的同源性,与最近克隆的小鼠巨噬细胞炎性蛋白(MIP)-1α受体有54%的同源性(高,J.L.,和墨菲,P.M.(1995年)《生物化学杂志》270,17494 - 17501)。对小鼠组织的Northern印迹分析表明,该mRNA在心脏、脾脏和肝脏中也有表达,在肺和脑中表达程度较低。CC趋化因子对稳定转染了受体cDNA的人胚肾(HEK)293细胞上125I标记的人RANTES(受激活调节、正常T细胞表达和分泌)结合的竞争顺序为:小鼠MIP-1α >> 人MIP-1β > 人RANTES > 小鼠RANTES > 小鼠MIP-1β > 人MCP-2 > 小鼠MCP-1(JE)> 人MIP-1α > 人MCP-3 > 人MCP-1。在所测试的趋化因子中,只有小鼠MIP-1α、人和小鼠MIP-1β以及RANTES、人MCP-2和JE能够诱导表达该受体的、用fura-2负载的HEK 293细胞内Ca2+的动员。这些结果表明,该受体作为高亲和力的小鼠MIP-1α受体发挥作用;然而,它可能是小鼠中几种CC趋化因子生物活性的重要靶点。